Atrial Fibrillation

Showing NaN - NaN of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atrial Fibrillation Trial in Worldwide (OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator)

Not yet recruiting
  • Atrial Fibrillation
  • OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator
  • Aalst, Belgium
  • +12 more
Jul 25, 2023

Atrial Fibrillation Trial in Worldwide (Milvexian, Apixaban, Placebo)

Not yet recruiting
  • Atrial Fibrillation
  • Alexander City, Alabama
  • +1158 more
Feb 24, 2023

Intracranial Hemorrhages, Atrial Fibrillation Trial in Worldwide (Edoxaban, Non-anticoagulant medical therapy)

Recruiting
  • Intracranial Hemorrhages
  • Atrial Fibrillation
  • Elk Grove Village, Illinois
  • +152 more
Jan 23, 2023

Atrial Fibrillation Trial in Canada, New Zealand, United States (HBI-3000, Placebo)

Recruiting
  • Atrial Fibrillation
  • Birmingham, Alabama
  • +20 more
Jan 23, 2023

Persistent Atrial Fibrillation, Atrial Fibrillation Trial in Worldwide (Radiofrequency Ablation)

Recruiting
  • Persistent Atrial Fibrillation
  • Atrial Fibrillation
  • Radiofrequency Ablation
  • Birmingham, Alabama
  • +28 more
Jan 17, 2023

Atrial Fibrillation, Stroke, Bleeding Trial in Canada, Germany, United States (Antiplatelet-only strategy, Oral Anticoagulant

Recruiting
  • Atrial Fibrillation
  • +2 more
  • Antiplatelet-only strategy
  • Oral Anticoagulant plus background antiplatelet therapy
  • Little Rock, Arkansas
  • +73 more
Jan 12, 2023

Prevention of Stroke or Systemic Embolism, Atrial Fibrillation Trial in Worldwide (Asundexian (BAY2433334), Apixaban, Asundexian

Recruiting
  • Prevention of Stroke or Systemic Embolism
  • Atrial Fibrillation
  • Asundexian (BAY2433334)
  • +3 more
  • Dothan, Alabama
  • +1128 more
Jan 5, 2023

Atrial Fibrillation Trial (Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic,

Recruiting
  • Atrial Fibrillation
  • Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic, drug-refractory PsAF.
  • Montréal, Quebec, Canada
  • +1 more
Dec 13, 2022

Atrial Fibrillation, Atrial Flutter Trial in Worldwide (Colchicine, Placebo)

Recruiting
  • Atrial Fibrillation
  • Atrial Flutter
  • Weston, Florida
  • +45 more
Nov 3, 2022

Stroke, Atrial Fibrillation Trial in Canada, Denmark (Investigators can choose from one of four Non-vitamin K oral

Recruiting
  • Stroke
  • Atrial Fibrillation
  • Non-vitamin K oral anticoagulant (NOAC)
  • Concord, New South Wales, Australia
  • +46 more
Oct 21, 2022

Genetic Predisposition, Atrial Fibrillation Trial in Montréal (Resting ECG (if first visit is done on site only), 24-hour

Enrolling by invitation
  • Genetic Predisposition
  • Atrial Fibrillation
  • Resting ECG (if first visit is done on site only)
  • +2 more
  • Montréal, Quebec, Canada
    Montreal Heart Institute
Aug 30, 2022

Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Fibrillation, Persistent Trial in Canada (Cryoballoon-based PVI,

Active, not recruiting
  • Atrial Fibrillation
  • +12 more
  • Cryoballoon-based PVI
  • Anti-Arrhythmic Drug Therapy
  • Calgary, Alberta, Canada
  • +17 more
Aug 22, 2022

Atrial Fibrillation Trial in Montreal (Bicaval cannulation, Cavoatrial cannulation)

Recruiting
  • Atrial Fibrillation
  • Bicaval cannulation
  • Cavoatrial cannulation
  • Montreal, Quebec, Canada
    Jewish General Hospital.
Aug 17, 2022

Atrial Fibrillation Trial in Canada, Netherlands (Etripamil, Placebo)

Recruiting
  • Atrial Fibrillation
  • Halifax, Nova Scotia, Canada
  • +18 more
Aug 2, 2022

Atrial Fibrillation Trial in Canada (Vernakalant, Procainamide)

Recruiting
  • Atrial Fibrillation
  • Edmonton, Alberta, Canada
  • +13 more
Jul 12, 2022

Atrial Fibrillation Trial in Montréal (QDOT MICRO System)

Completed
  • Atrial Fibrillation
  • QDOT MICRO System
  • Montréal, Quebec, Canada
    Institut de Cardiologie de Montréal (Montreal Heart Institute)
Apr 18, 2022

Randomized Ablation-based AF Rhythm-control Versus Rate-control

Not yet recruiting
  • Atrial Fibrillation
  • Heart Failure
    • Porto Alegre, Brazil
    • +17 more
    Apr 6, 2022

    Atrial Fibrillation, Stroke Trial in Worldwide (Rivaroxaban, Acetylsalicylic acid)

    Recruiting
    • Atrial Fibrillation
    • Stroke
    • Canberra, Australian Capital Territory, Australia
    • +54 more
    Mar 23, 2022

    Atrial Fibrillation, Catheter Ablation, Radiofrequency Catheter Ablation Trial in Ottawa, Montreal (Cryoballoon ablation,

    Not yet recruiting
    • Atrial Fibrillation
    • +2 more
    • Cryoballoon ablation
    • Radiofrequency catheter ablation +EPS guided trigger and substrate ablation
    • Ottawa, Ontario, Canada
    • +1 more
    Mar 23, 2022

    Atrial Fibrillation Trial in Worldwide (Edoxaban-based Regimen, VKA-based Regimen)

    Completed
    • Atrial Fibrillation
    • Edoxaban-based Regimen
    • VKA-based Regimen
    • Birmingham, Alabama
    • +229 more
    Mar 22, 2022

    Heart Disease, CHF, Atrial Fibrillation Trial in Canada (Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD)

    Recruiting
    • Heart Disease
    • +2 more
    • Optimal Medical therapy plus ICD
    • Optimal Medical therapy plus CRT/ICD
    • Calgary, Alberta, Canada
    • +15 more
    Mar 23, 2022

    Atrial Fibrillation Trial in Montreal (OMEGA-3, Placebo soybean oil)

    Completed
    • Atrial Fibrillation
    • Montreal, Quebec, Canada
      Montreal Heart Institute Coordinating Center
    Mar 1, 2022

    Atrial Fibrillation Trial in Canada (Catheter ablation)

    Recruiting
    • Atrial Fibrillation
    • Catheter ablation
    • Calgary, Alberta, Canada
    • +14 more
    Nov 2, 2021

    Heart Failure, Atrial Fibrillation Trial in Worldwide (Rhythm control, Rate Control)

    Completed
    • Heart Failure
    • Atrial Fibrillation
    • Rhythm control
    • Rate Control
    • Porto Alegre, Rio Grande Do Sul, Brazil
    • +20 more
    Oct 13, 2021

    ATRIAL FIBRILLATION Trial in Montreal (Rivaroxaban, standard of care)

    Recruiting
    • ATRIAL FIBRILLATION
    • Montreal, Quebec, Canada
      Montreal Heart Institute
    Sep 24, 2021